Chipotle, Q4

Ford Q4 2024 Earnings Preview: Inventory, pricing concerns under spotlight
Ford (NYSE:F) is scheduled to announce Q4 earnings results on Wednesday, February 5th, after market close. Wells Fargo ...
GSK beats Q4 earnings estimates, lifts 2031 sales target
GSK forecast sales in 2025 to grow 3%-5% and reported better-than-expected fourth-quarter earnings, as strength in its HIV ...
Why Intel's Q4 Earnings Report Was Much Better Than It Looked. Is The Turnaround Story Intact?
After falling behind Taiwan Semiconductor Manufacturing (NYSE: TSM) in process technology, Intel embarked on an ambitious and ...
Novo Nordisk Q4 Profit Beats Expectations, Sees Slower Growth in 2025
LONDON/COPENHAGEN (Reuters) -Wegovy maker Novo Nordisk on Wednesday forecast slower sales growth for 2025 than 2024, a blow ...
Santander Brasil's Net Profit Surges 75% in Q4
Santander Brasil's NII - earnings on loans minus deposit costs - rose 16% in the fourth quarter to 15.98 billion reais, while ...
Harley-Davidson stock slips after Q4 loss amid ‘cyclical headwinds for discretionary products’
The high-interest rate environment has impacted consumer confidence, according to Harley-Davidson CEO Jochen Zeitz ...
Uber reports Q4 EPS $3.21 vs. 66c last year
Reports Q4 revenue $12B, consensus $11.77B. Gross Bookings grew 18% year-over-year and 21% year-over-year on a constant currency basis. “Uber ...
Santander Bank Polska's Q4 net profit slips but beats expectations
The Polish unit of Santander Bank posted a 7% fall in its preliminary fourth-quarter net profit on Wednesday, hit by rising ...
Amgen Surpasses Q4 Earnings Forecasts
Amgen reported strong fourth-quarter earnings, driven by strategic acquisitions and robust product sales growth.
Bunge Q4 profit falls on weak oilseed margins; 2025 outlook weakens
Bunge's agribusiness segment, which represents over 80% of its total revenue, saw adjusted core earnings decline to $364 ...
Novo Nordisk CEO Lars Fruergaard Jørgensen on Q4 results, Wegovy demand and drug pipeline outlook
CNBC’s Angelica Peebles and Novo Nordisk CEO Lars Fruergaard Jørgensen join 'Squawk Box' to discuss the company's quarterly earnings results, demand for Wegovy, drug pipeline outlook, Cagrisema ...